Gheorghe‐Andrei Dan

ORCID: 0000-0001-9867-2582
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Cardiac electrophysiology and arrhythmias
  • Cardiac pacing and defibrillation studies
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiovascular Function and Risk Factors
  • Cardiac Imaging and Diagnostics
  • Acute Myocardial Infarction Research
  • Heart Failure Treatment and Management
  • Venous Thromboembolism Diagnosis and Management
  • Cardiovascular Syncope and Autonomic Disorders
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Systemic Lupus Erythematosus Research
  • Inflammatory Biomarkers in Disease Prognosis
  • Heart Rate Variability and Autonomic Control
  • Pericarditis and Cardiac Tamponade
  • Acute Ischemic Stroke Management
  • Systemic Sclerosis and Related Diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Platelet Disorders and Treatments
  • Cardiac Health and Mental Health
  • Cardiac Valve Diseases and Treatments
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Pharmaceutical Economics and Policy
  • Cardiovascular Disease and Adiposity

Carol Davila University of Medicine and Pharmacy
2016-2025

Spitalul Clinic Colentina
2015-2025

Academy of Romanian Scientists
2024-2025

Romanian Academy
2024-2025

University of Bucharest
2016-2022

International Society of Nephrology
2016-2022

Anderson Orthopaedic Clinic
2021

Heart Rhythm Society
2021

Memorial Healthcare System
2018

Massachusetts General Hospital
2016

Gerhard Hindricks Tatjana Potpara Nikolaos Dagres Elena Arbelo Jeroen J. Bax and 95 more Carina Blomström‐Lundqvist Giuseppe Boriani Manuel Castellá Gheorghe‐Andrei Dan Polychronis Dilaveris Laurent Fauchier Gerasimos Filippatos Jonathan M. Kalman Mark La Meir Deirdre A. Lane Jean‐Pierre Lebeau Maddalena Lettino Gregory Y.H. Lip Fausto J. Pinto G. Neil Thomas Marco Valgimigli Isabelle C. Van Gelder Bart P. van Putte Caroline L Watkins Paulus Kirchhof Michael Kühne Victor Aboyans Anders Ahlsson Paweł Balsam Johann Bauersachs Stefano Benussi Axel Brandes Frieder Braunschweig A John Camm Davide Capodanno Barbara Casadei David Conen Harry J.G.M. Crijns Victoria Delgado Dobromir Dobrev Heinz Drexel Lars Eckardt Donna Fitzsimons Thierry Folliguet Chris P Gale Bülent Görenek Karl Georg Hæusler Hein Heidbüchel Bernard Iung Hugo A Katus Dipak Kotecha Ulf Landmesser Christophe Leclercq Basil S. Lewis Julia Mascherbauer José Luís Merino Béla Merkely Lluı́s Mont Christian Mueller Klaudia Vivien Nagy Jonas Oldgren Nikola Pavlović Roberto F.E. Pedretti Steffen E. Petersen Jonathan P. Piccini Bogdan A. Popescu Helmut Pürerfellner Dimitrios J. Richter Marco Roffi Andrea Rubboli Douglas S. Scherr Renate B. Schnabel Iain A Simpson Е. V. Shlyakhto Moritz F. Sinner Jan Steffel Miguel Sousa‐Uva Piotr Suwalski Martin Svetlošák Rhian M. Touyz Nikolaos Dagres Elena Arbelo Jeroen J. Bax Carina Blomström‐Lundqvist Giuseppe Boriani Manuel Castellá Gheorghe‐Andrei Dan Polychronis Dilaveris Laurent Fauchier Gerasimos Filippatos Jonathan M. Kalman Mark La Meir Deirdre A. Lane Jean‐Pierre Lebeau Maddalena Lettino Gregory Y.H. Lip Fausto J. Pinto G. Neil Thomas Marco Valgimigli Isabelle C. Van Gelder

Supplementary Table 9, column 'Edoxaban', row 'eGFR category', '95 mL/min' (page 15). The cell should be coloured green instead of yellow. It also read 60 mginstead mg (use with caution in 'supranormal' renal function).In the above-indicated cell, a footnote has been added to state: Edoxaban used patients high creatinine clearance only after careful evaluation individual thromboembolic and bleeding risk.Supplementary 'Dose reduction selected patients' 16). reduced 30 once daily if any...

10.1093/eurheartj/ehaa612 article EN European Heart Journal 2020-07-17
Robert A. Byrne Xavier Rosselló J J Coughlan Emanuele Barbato Colin Berry and 95 more Alaide Chieffo Marc J. Claeys Gheorghe‐Andrei Dan Marc R. Dweck Mary Galbraith Martine Gilard Lynne Hinterbuchner Ewa A. Jankowska Peter Jüni Takeshi Kimura Vijay Kunadian Margrét Leósdóttir Roberto Lorusso Roberto F.E. Pedretti Angelos G. Rigopoulos María Rubini Giménez Hölger Thiele Pascal Vranckx Sven Waßmann Nanette K. Wenger Borja Ibáñez Sigrun Halvorsen Stefan James Magdy Abdelhamid Victor Aboyans Nina Ajmone Marsan Sotiris Antoniou Riccardo Asteggiano Maria Bäck Davide Capodanno Rubén Casado-Arroyo Salvatore Cassese Jelena Čelutkienė Maja Čikeš Jean‐Philippe Collet Grégory Ducrocq Volkmar Falk Laurent Fauchier Tobias Geisler Diana A. Gorog Lene Holmvang Tiny Jaarsma Hywel Wynne Jones Lars Køber Konstantinos C. Koskinas Dipak Kotecha Konstantin A. Krychtiuk Ulf Landmesser George Lazaros Basil S. Lewis Bertil Lindahl Aleš Linhart Maja‐Lisa Løchen Mamas A. Mamas John W. McEvoy Borislava Mihaylova Richard Mindham Christian Mueller Lis Neubeck Josef Niebauer Jens Cosedis Nielsen Alexander Niessner Valeria Paradies Agnès Pasquet Steffen E. Petersen Eva Prescott Amina Rakisheva Bianca Rocca Giuseppe Rosano Leyla Elif Sade François Schiele Jolanta M. Siller‐Matula Christian Sticherling Robert F. Storey Matthias Thielmann Christiaan Vrints Stephan Windecker Rune Wiseth Adam Witkowski Mohammed El Amine Bouzid Hamlet Hayrapetyan Bernhard Metzler Patrizio Lancellotti Mugdim Bajrić Kiril Karamfiloff Andreas Mitsis Petr Ošťádal Rikke Sørensen Tamer Elwasify Toomas Marandi Essi Ryödi Jean‐Philippe Collet Archil Chukhrukidze Julinda Mehilli Periklis Davlouros

10.1093/eurheartj/ehad191 article EN European Heart Journal 2023-08-25

Recent case-series of small size implied a pathophysiological association between coronavirus disease 2019 (COVID-19) and severe large-vessel acute ischemic stroke. Given that strokes are typically associated with poor prognosis can be very efficiently treated recanalization techniques, confirmation this putative is urgently warranted in large representative patient cohort to alert stroke clinicians, inform pre- in-hospital pathways. We pooled all consecutive patients hospitalized...

10.1161/strokeaha.120.031208 article EN Stroke 2020-07-09

Device-detected atrial high-rate episodes (AHREs) are arrhythmias detected by implanted cardiac devices. AHREs resemble fibrillation but rare and brief. Whether the occurrence of in patients without (as documented on a conventional electrocardiogram [ECG]) justifies initiation anticoagulants is not known. Download PDF Research Summary. We conducted an event-driven, double-blind, double-dummy, randomized trial involving 65 years age or older who had lasting for at least 6 minutes one...

10.1056/nejmoa2303062 article EN New England Journal of Medicine 2023-08-25

Since the advent of non-vitamin K antagonist oral anticoagulant (NOAC) agents, which act as direct thrombin inhibitors or Factor Xa, clinicians are provided with valuable alternatives to vitamin antagonists (VKAs). At same time, electrophysiologists frequently perform more invasive procedures, increasingly involving left chambers heart. Thus, they constantly faced dilemma balancing risk for thromboembolic events and bleeding complications. These changes in rapidly evolving field mandate an...

10.1093/europace/euv190 article EN EP Europace 2015-06-23
Robert A. Byrne Xavier Rosselló J J Coughlan Emanuele Barbato Colin Berry and 95 more Alaide Chieffo Marc J. Claeys Gheorghe‐Andrei Dan Marc R. Dweck Mary Galbraith Martine Gilard Lynne Hinterbuchner Ewa A. Jankowska Peter Jüni Takeshi Kimura Vijay Kunadian Margrét Leósdóttir Roberto Lorusso Roberto F.E. Pedretti Angelos G. Rigopoulos María Rubini Giménez Hölger Thiele Pascal Vranckx Sven Waßmann Nanette K. Wenger Borja Ibáñez Sigrun Halvorsen Stefan James Magdy Abdelhamid Victor Aboyans Nina Ajmone Marsan Sotiris Antoniou Riccardo Asteggiano Maria Bäck Davide Capodanno Rubén Casado-Arroyo Salvatore Cassese Jelena Čelutkienė Maja Čikeš Jean‐Philippe Collet Grégory Ducrocq Volkmar Falk Laurent Fauchier Tobias Geisler Diana A. Gorog Lene Holmvang Tiny Jaarsma Hywel Wynne Jones Lars Køber Konstantinos C. Koskinas Dipak Kotecha Konstantin A. Krychtiuk Ulf Landmesser George Lazaros Basil S. Lewis Bertil Lindahl Aleš Linhart Maja‐Lisa Løchen Mamas A. Mamas John W. McEvoy Borislava Mihaylova Richard Mindham Christian Mueller Lis Neubeck Josef Niebauer Jens Cosedis Nielsen Alexander Niessner Valeria Paradies Agnès Pasquet Steffen E. Petersen Eva Prescott Amina Rakisheva Bianca Rocca Giuseppe Rosano Leyla Elif Sade François Schiele Jolanta M. Siller‐Matula Christian Sticherling Robert F. Storey Matthias Thielmann Christiaan Vrints Stephan Windecker Rune Wiseth Adam Witkowski Mohammed El Amine Bouzid Hamlet Hayrapetyan Bernhard Metzler Patrizio Lancellotti Mugdim Bajrić Kiril Karamfiloff Andreas Mitsis Petr Ošťádal Rikke Sørensen Tamer Elwasify Toomas Marandi Essi Ryödi Jean‐Philippe Collet Archil Chukhrukidze Julinda Mehilli Periklis Davlouros

Journal Article Corrected proof Guidelines 2023 ESC for the management of acute coronary syndromes: Developed by task force on syndromes European Society Cardiology (ESC) Get access Robert A Byrne, Byrne (Ireland) Corresponding authors: A. Department and Cardiovascular Research Institute (CVRI) Dublin, Mater Private Network, Ireland, School Pharmacy Biomolecular Sciences, RCSI University Medicine Health Ireland. Tel: +353-1-2483190, E-mail: robertabyrne@rcsi.ie...

10.1093/ehjacc/zuad107 article EN European Heart Journal Acute Cardiovascular Care 2023-09-22

The kidney exerts multiple functions, and pathophysiological interactions between the heart have important clinical implications, but it has only recently become clear that these should be studied across whole spectrum of reduced function not in cases with severe, end-stage renal disease (ESRD), as been done for many years.1 prevalence chronic (CKD), defined a glomerular filtration rate (GFR) 3 months, exceeds 10% adult population reaches 47% subjects older than 70 years, according to data...

10.1093/europace/euv202 article EN EP Europace 2015-06-24

Abstract Background and Aims Patients with long atrial high-rate episodes (AHREs) ≥24 h stroke risk factors are often treated anticoagulation for prevention. Anticoagulation has never been compared no in these patients. Methods This secondary pre-specified analysis of the Non-vitamin K antagonist Oral anticoagulants patients Atrial High-rate (NOAH-AFNET 6) trial examined interactions between AHRE duration at baseline edoxaban placebo factors. The primary efficacy outcome was a composite...

10.1093/eurheartj/ehad771 article EN cc-by-nc European Heart Journal 2023-11-12

Atrial high-rate episodes (AHRE) are atrial tachyarrhythmias detected by continuous rhythm monitoring pacemakers, defibrillators, or implantable cardiac monitors. occur in 10-30% of elderly patients without fibrillation. However, it remains unclear whether the presence these arrhythmias has therapeutic consequences. The AHRE increases risk stroke compared with AHRE. Oral anticoagulation would have potential to reduce but is also associated a rate major bleeding ∼2%/year. appears be lower...

10.1093/europace/euad166 article EN cc-by-nc EP Europace 2023-06-22

Abstract ESC Guidelines provide best practice, evidence-based recommendations for diagnosing and treating patients with cardiovascular diseases. It is not always possible practices to be followed, however, particularly in low-resource settings. To address this issue, a set of guideline-related documents were created identify key priorities users these The highlight the related describe strategies clinicians approach implementation or discuss alternatives which are line intention...

10.1093/ehjqcco/qcae107 article EN other-oa European Heart Journal - Quality of Care and Clinical Outcomes 2025-03-28
Coming Soon ...